• news

Celaid awarded the "JHVS2022 Ventur Award"

Celaid Therapeutics received the "JHVS2022 Venture Award" as a venture company that made an especially outstanding pitch in the "JHVS SHOWCASE" held by exhibitors at the "Japan Healthcare Venture Summit 2022".
The award is given to ventures and academia that have seeds that are expected to lead to pharmaceuticals, medical devices, regenerative medicine, and other products, and whose potential for practical application, the potential of the seeds, and presentation techniques are comprehensively judged to be promising.

The JHVS2022 Venture Award winners will be honored at the "JHVS2022 Symposium" hosted by the Ministry of Health, Labor and Welfare on Thursday, February 2 and Friday, February 3, 2023.

Copyright© セレイドセラピューティクス - 細胞治療(造血幹細胞) , 2024 All Rights Reserved Powered by STINGER.